Dexter: Resurrection has confirmed the returns of a few original characters in the new sequel, fixing a complaint from New ...
In 2025’s rapidly evolving environment, prioritizing optimal health and peak performance is more critical than ever. As more ...
Sanofi's phase 3 study shows Sarclisa SC matches IV formulation in efficacy for relapsed myeloma. Regulatory submissions are planned for 2025.